These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28457013)

  • 1. e-Health-based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study.
    Prochaska JH; Göbel S; Keller K; Coldewey M; Ullmann A; Lamparter H; Schulz A; Schinzel H; Bickel C; Lauterbach M; Michal M; Hardt R; Binder H; Espinola-Klein C; Lackner KJ; Ten Cate H; Münzel T; Wild PS
    J Thromb Haemost; 2017 Jul; 15(7):1375-1385. PubMed ID: 28457013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telemedicine-Based Specialized Care Improves the Outcome of Anticoagulated Individuals with Venous Thromboembolism-Results from the thrombEVAL Study.
    Keller K; Göbel S; Ten Cate V; Panova-Noeva M; Eggebrecht L; Nagler M; Coldewey M; Foebel M; Bickel C; Lauterbach M; Espinola-Klein C; Lackner KJ; Cate HT; Münzel T; Wild PS; H Prochaska J
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33066188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtherapeutic Anticoagulation Control under Treatment with Vitamin K-Antagonists-Data from a Specialized Coagulation Service.
    Prochaska JH; Hausner C; Nagler M; Göbel S; Eggebrecht L; Panova-Noeva M; Arnold N; Lauterbach M; Bickel C; Michal M; Hardt R; Espinola-Klein C; Lackner KJ; Münzel T; Wild PS
    Thromb Haemost; 2019 Aug; 119(8):1347-1357. PubMed ID: 31183847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study.
    Eggebrecht L; Ludolph P; Göbel S; Panova-Noeva M; Arnold N; Nagler M; Bickel C; Lauterbach M; Hardt R; Cate HT; Lackner KJ; Espinola-Klein C; Münzel T; Prochaska JH; Wild PS
    Sci Rep; 2021 Jan; 11(1):2577. PubMed ID: 33510343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL.
    Prochaska JH; Göbel S; Keller K; Coldewey M; Ullmann A; Lamparter H; Jünger C; Al-Bayati Z; Baer C; Walter U; Bickel C; ten Cate H; Münzel T; Wild PS
    BMC Med; 2015 Jan; 13():14. PubMed ID: 25616558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme.
    Prochaska JH; Coldewey M; Göbel S; Keller K; Hendelmeier M; Konstantinides S; Münzel T; Wild PS;
    Eur J Prev Cardiol; 2015 May; 22(5):622-8. PubMed ID: 24685605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K Antagonists.
    Eggebrecht L; Nagler M; Göbel S; Lamparter H; Keller K; Wagner B; Panova-Noeva M; Ten Cate V; Bickel C; Lauterbach M; Espinola-Klein C; Hardt R; Münzel T; Prochaska JH; Wild PS
    J Am Geriatr Soc; 2019 Mar; 67(3):463-470. PubMed ID: 30536652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: clinical outcomes in a single centre cohort after long-term follow-up.
    Corrochano M; Jiménez B; Millón J; Gich I; Rambla M; Gil E; Caparrós P; Macho R; Souto JC
    BMC Cardiovasc Disord; 2020 Apr; 20(1):166. PubMed ID: 32276619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relevance of depressive symptoms for the outcome of patients receiving vitamin K antagonists: results from the thrombEVAL cohort study.
    Michal M; Eggebrecht L; Göbel S; Panova-Noeva M; Nagler M; Arnold N; Lauterbach M; Bickel C; Wiltink J; Beutel ME; Münzel T; Wild PS; Prochaska JH
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):271-279. PubMed ID: 31922545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study.
    Göbel S; Prochaska JH; Eggebrecht L; Schmitz R; Jünger C; Lamparter H; Nagler M; Keller K; Coldewey M; Tröbs SO; Diestelmeier S; Schwuchow-Thonke S; Bickel C; Lauterbach M; Lackner KJ; Cate HT; Münzel T; Hardt R; Wild PS
    Thromb Haemost; 2018 Nov; 118(11):1930-1939. PubMed ID: 30357779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized Management of Oral Anticoagulation Therapy Improves Outcome in Patients with Chronic Renal Insufficiency.
    Lauterbach M; Uhrich E; Eggebrecht L; Göbel S; Panova-Noeva M; Nagler M; Ten Cate V; Bickel C; Espinola-Klein C; Münzel T; Wild PS; Prochaska JH
    J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32121153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure.
    Prochaska JH; Göbel S; Nagler M; Knöpfler T; Eggebrecht L; Lamparter H; Panova-Noeva M; Keller K; Coldewey M; Bickel C; Lauterbach M; Hardt R; Espinola-Klein C; Ten Cate H; Rostock T; Münzel T; Wild PS
    Clin Res Cardiol; 2018 Dec; 107(12):1170-1179. PubMed ID: 29948286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation.
    Sharma P; Scotland G; Cruickshank M; Tassie E; Fraser C; Burton C; Croal B; Ramsay CR; Brazzelli M
    Health Technol Assess; 2015 Jun; 19(48):1-172. PubMed ID: 26138549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
    Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
    Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment: a controlled follow-up study in Spain.
    Duran-Parrondo C; Vazquez-Lago JM; Campos-Lopez AM; Figueiras A
    Drug Saf; 2011 Jun; 34(6):489-500. PubMed ID: 21585221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists.
    Abumuaileq RR; Abu-Assi E; Raposeiras-Roubin S; López-López A; Redondo-Diéguez A; Álvarez-Iglesias D; Rodríguez-Mañero M; Peña-Gil C; González-Juanatey JR
    Europace; 2015 May; 17(5):711-7. PubMed ID: 25662984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
    Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
    Nagler M; Angelillo-Scherrer A; Méan M; Limacher A; Abbal C; Righini M; Beer JH; Osterwalder J; Frauchiger B; Aschwanden M; Matter CM; Kucher N; Cornuz J; Banyai M; Husmann M; Staub D; Mazzolai L; Hugli O; Rodondi N; Aujesky D
    J Thromb Haemost; 2017 Nov; 15(11):2165-2175. PubMed ID: 28834238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.